Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance

Despite unprecedented responses of some cancers to immune checkpoint blockade (ICB) therapies, the application of checkpoint inhibitors in pancreatic cancer has been unsuccessful. Glucocorticoids and glucocorticoid receptor (GR) signaling are long thought to suppress immunity by acting on immune cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Yalan, Xia, Xianghou, Zhao, Yang, Zhao, Zilong, Martinez, Consuelo, Yin, Wenjuan, Yao, Jun, Hang, Qinglei, Wu, Weiche, Zhang, Jie, Yu, Yang, Xia, Weiya, Yao, Fan, Zhao, Di, Sun, Yutong, Ying, Haoqiang, Hung, Mien-Chie, Ma, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649069/
https://www.ncbi.nlm.nih.gov/pubmed/34873175
http://dx.doi.org/10.1038/s41467-021-27349-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649069/
https://www.ncbi.nlm.nih.gov/pubmed/34873175
http://dx.doi.org/10.1038/s41467-021-27349-7

Ejemplares similares